Pfizer’s Glucotrol XL Generic Not Cutting Into Andrx’ Market Share
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer's introduction of its own Glucotrol XL generic has not impacted Andrx' market share for glipizide extended-release, the generic company said during an Aug. 10 earnings call